Voyageur Pharmaceuticals Ltd. filed its Annual on Mar 30, 2023 for the period ending Nov 30, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 CAD | -15.38% | +10.00% | -26.67% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.67% | 6.62M | |
+38.87% | 727B | |
+30.57% | 592B | |
-8.08% | 347B | |
+15.28% | 319B | |
-0.70% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.39% | 160B |
- Stock Market
- Equities
- VM Stock
- News Voyageur Pharmaceuticals Ltd.
- Voyageur Pharmaceuticals Ltd. Auditor Raises 'Going Concern' Doubt